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The purpose of this paper is to evaluate factors affecting the outcome of cholangitis after PTBD in
jaundiced cancer patients. Twenty nine patients with neoplastic jaundice (male/female ratio 13/16,
median age 55 years) with full clinical data, were treated by PTBD and developed cholangitis at a
median of 9 days later. Four patients (14%) died of biliary sepsis a median of one month after PTBD
while the other 25 survived a median of 6 months, with one week median duration of cholangitis. The
probability of the cholangitis resolving was analyzed by time to resolution and it was found that 50% and
100% of the recoveries occurred 5 and 9 months respectively from the onset of the complication.
The series was analyzed to determine the role of several variables (disease/patient/treatment related)
in the resolution of cholangitis. Only a low stricture site, a large initial drainage catheter (10F) and a
temperature increase exceeding 39 C were correlated with a positive outcome. We conclude that
PTBD-related cholangitis has, in our experience, a good chance of cure, low mortality rate and
satisfactory 6 months median survival.
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Although recent experiencel-3 suggests a decrease in septic problems after percuta-
neous transhepatic biliary drainage (PTBD), cholangitis still occurs with a median
prevalence of 30%. Some factors were associated with a higher risk of cholangitis
due to PTBD, in a previous report of ours4, but little is known about factors
influencing the clinical outcome in these patients. In an attempt to answer this
question, we examined retrospectively the clinical data of 29 episodes of cholangitis
after PTBD.
PATIENTS AND METHODS
Our Institutional policy for dealing with obstructive jaundice is" Percutaneous
Transhepatic Cholangiography (PTC) to provide accurate images, followed if
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necessary by Percutaneous Transhepatic Biliary Drainage (PTBD); this will reduce
bilirubin preoperatively (5) with an improvement in hepatic regeneration and
Kupffer cell response, and it provides definitive treatment if there is no surgical
option. In the period from 1985 to 1989, 306 PTBDs were performed at the Istituto
Nazionale Tumori of Milan.
We define cholangitis or recurrent cholangitis as a single or recurrent septic event
with spiking fever exceeding 38.5 C, weakness sometimes accompanied by prost-
ration, chills, hypotension and no sign of sepsis elsewhere.
The purpose of this paper is to define the mortality rate of cholangitis and the
prognostic factors associated with a positive outcome. The incidence of cholangitis
was 17.5% in cancer patients and 10.5% in non cancer patients with a total of 46
occurrences, six had inadequate clinical records seven had non neoplastic strictures
and four had had major liver surgery so that their clinical septic course could be
confused with postoperative subphrenic abscess, leaving only 29 occurrences in 28
patients for the present study.
In present series of 29 cancer patients (13 males and 16 females, median age 55
years, range 32 to 73 years), all had a histologically proven neoplastic stricture due
to: primary liver cancer (10) or liver metastasis from colorectal cancer (9), gastric
cancer (4), breast cancer (1) or gynecological malignancy (1); 4 subjects had
pancreatic cancer and two of these had synchronous liver metastases. PTBD was
the only procedure used to treat these patients who were poor candidates for other
forms of palliation.
Data defining the patients’ general condition, biochemistry, aetiology of jaundice
and characteristics of the stricture are given in Table 1. Table 2 gives information
about PTBD itself as well as procedures undertaken to improve bile flow through
the catheter. Eighteen patients had an 8F and 11 had a 10F catheter. At the onset of
cholangitis, it was externally opened in 7 patients and closed in 22, its tip passing
through and below the stricture.
Table 1 Characteristics of the series before the occurrence of cholangitis
Variables N. patients Median (Range)
Demographic/clinical
sex M/F 13/16
age (years)
perform status* 13
2 15
3
Tumor related
Primary liver carcinoma 10
liver metastasis 17
pancreatic cancer 2
above/at confluence 22
below 7
duodenal invasion
or infiltration 4
Biochemical
basal WB count/mL
Total bilirubin mgs%
55 (32-73)
7400 (3200-16000)
14 (3-34)
according to the ZUBROD-WHO scaleNEOPLASTIC JAUNDICE 289
Table 2 Variables recorded at the occurrence of cholangitis and after it
Variables N. patients
At the onset of cholangitis
onset from PTBD<8 days 13
>8 days 16
drainage external 7
internal 22
drainage diameter 8F 18
10F 11
8
drainage obstruction* no 21
temperature <39 22
>39 7
WB count/ml <18.100 15
>18.100 14
After the onset of cholangitis
number of 15
exchanges > 14
maximum diameter <12 F 24
employed >F 5
wash-outs employed yes 16
no 13
brushings yes 4
no 25
externally opened yes 25
no 4
broad spectrum antibiotics 19
specific anbitioticsb 10
systemic antibiotics 22
systemic+intrabiliary 7
injected antibiotics according to the lab resistence tests
n. days of antibiotic <13 18
therapy >13 11
reasological evidence.
At the onset of cholangitis median body temperature was 39C (range 38.5--40)
and the median white cell count was 18100/mL (7800-35000); bile was cultured and
antibiotic sensitivities determined. Therapeutic antibiotics were given for a median
of 13 days (range 5-40).
A third generation cephalosporin was administered to nineteen subjects; the
other ten were given specific antibiotics according to sensitivity tests. Twenty-two
patients were given intravenous antibiotics and seven had the drug injected into the
biliary tree through the catheter. Drainage catheters were changed once in 15
patients and more than once in 14 (median 3, range 2-11).
Follow-up time was a median of four months (range 1-27 months) from PTBD
until death.
The duration of cholangitis was defined as the number of days from onset to its
resolution indicated by an absence of clinical signs, no fever and a normal white cell
count.290 R. A. AUDISIO ET AL.
STATISTICAL EVALUATION
Each variable had two possibilities (Table 2) and the proportion of patients who
recovered from cholangitis was computed for each of the two categories. Statistical
significance of the difference between the two proportions obtained was tested by
Chi-square after arcsein transformation of the proportions6.
Statistical significance at the .05 level can only be achieved by having at least five
patients in the smallest group. Thus all variables with less than five subjects in one
of the two groups were not evaluated.
Patients who recovered from cholangitis were further evaluated to define a
possible role for each of the variables in producing a shorter clinical course.
RESULTS
Twenty five patients (86%) had a single episode of acute cholangitis; of these,
twenty one (72%) recovered and 4 (14%) died of sepsis related to cholangitis
lasting a median of one month. Four subjects suffered recurrences (14%).
Cholangitis occurred a median of 9 days from PTBD (range 1 day 7 months),
and lasted a median of 7 days (1-20 days). Sixteen patients died of progressive
malignancy a median of 6 months from PTBD and 2 died of other causes after 7 and
8 months respectively; seven subjects are alive a median of 8 months after PTBD.
Details concerning outcome and clinical course of cholangitis are reported in Table
3. Thirty-day mortality was 7% (2 patients, one of which died of neoplastic disease
without sepsis).
Out of the large number of variables considered (Tables 1 and 2), only a few
prognostic factors proved statistically related to a better prognosis in cholangitis: a
stricture below the confluence of the two main ducts, a large catheter (10F or more
in diameter) and a patient response suggested by an increase in body temperature
to greater than 39 C (Table 4).
All previously reported variables were also analyzed for correlation with the
duration of cholangitis but none was found.
Bacteriological examination of the bile sample was performed in 13 patients at
the onset of cholangitis: in one case Klebsiella was cultured alone, and in two cases
only Pseudomonas species were grown; most frequently (70% of the cultured
cases) the presence of enteric bacteria such as E. coli or Klebsiella species were
associated with St. epidermis, Str. anhemoliticus, Str. alpha hemoliticus, Str. beta
hemoliticus, Enterobacter species or Proteus mirabilis.
About half of the cholangitis sufferers, including those who may develop
recurrences, show resolution within 5 months, while none will resolve if it lasts
more than 10 months.
DISCUSSION
Although some authors claim that the diagnostic and therapeutic role of PTBD is
controversial7, the technique has been extensively used after the early experience
of Molnar and Stockum8. Several complications were reported, such as biliaryNEOPLASTIC JAUNDICE 291
Table 3 Clinical course and outcome of cholangitis after PTBD in neoplastic patients.
Outcome N. pts
Occurence
Median time of cholangitis Duration of
from PTBD from PTBD cholangitis
(range) (range) (range)
awm 7a 8 mos 3 days
(1-15 mos) 3 days-3 mos)
dpm 16b 6 mos 20 days
(1-28 mos) (1 day-7 mos)
doc 2 8 mos
(7-8 mos) (3-6 mos)
dbs 4 mo 11 dys
(1-4 mos) (2-16days)
6 days
(1-20 days)
7 days
(5-12 days)
(3-7 days)
mo
(15-80 days)
awm=alive with malignancy
dpm=died of progressive malignancy
doc=died of other causes (heart attack and coagulopathy)
dbs=died of biliary sepsis
a: patients are alive with recurrent cholangitis after 8 and 16 months
b: patients survived 5 and 10 months with recurrent cholangitis
Table 4 Statistically significant variables related to positive resolution of cholangitis.
Variables N. patients Resolved p
stricture above/at the confluence
stricture below/at the confluence
first drainage <10F
first drainage > 10F
temperature at <39
cholangitis >39
22 14 0.01
7 7
18 11 0.05
11 10
22 14 <0.01
7 7
leakage, bleeding, electrolyte and nutritional deficiencies, but sepsis related prob-
lems stand out. Cholangitis is a frequent complication, its prevalence ranging from
14.5% (2) to almost 50% (9-11) and it is more frequently observed in patients with
malignancies (54%) than in those with benign disease (22%)
12
It is well documented by Thompson
13 that neoplastic jaundice is more prone to
cause recurrent cholangitis and more likely to be fatal than is the case with stones.
The availability of a large number of effective antibiotic drugs and biliary
decompression makes the difference between the present mortality rate for cholan-
gitis ranging from 9 to 40% (9,13-16) compared with the early work of Rogers
7
who reported a 100% mortality rate; despite this, biliary sepsis can cause septic
shock and become a life-threatening condition. A careful technique followed by
good care of the catheter, including flushing with saline to remove sludge and clots,
helped in reducing the prevalence of septic episodes from 38.5% (4) in the 1982-84292 R. A. AUDISIO ET AL.
INT series to 17.5% (1) in a 1986 update, and down to 15% described in this report.
This figure compares well With the prevalence of cholangitis among patients with
malignant biliary obstruction treated with endoscopic biliary endoprosthesis (17-
20%) as recently reported 8"19.
Only a few factors have statistical importance in resolving cholangitis. The
significant associations we have found can have only an indicative value due to the
high number of comparisons performed: the anatomical site of the neoplastic
stricture is one, since it is evident that low stenoses are better drained. Secondly,
biological features such as an increase in body temperature (>39 C) are both
statistically related to a more favourable outcome. Advantageous for a higher
probability of resolving biliary sepsis is also a maximum fl0w through the catheter
even in the presence of thick bile or debris when a larger catheter (10 F or more) is
employed; this recommendation needs to be emphasized since it is the only variable
we can effectively modify2-22.
Repeated exchanges were also performed, both by the use of larger diameter
catheters and repeated wash-outs with saline solution. It was also decided to
administer antibiotics suggested by bacteriological tests instead of broad spectrum
drugs. The intrabiliary route by direct injection through the catheter used for the
administration of parenteral antibiotics. No significant advantage was achieved by
these extensive nursing procedures in the present series. Several other factors
aimed to improve bile flow might possibly be helpful in positively resolving
cholangitis or in shortening its course (external opening, correct positioning of the
side holes and brushings of the catheter)
23 but the limited number in the series does
not allow statistical comparison.
We should consider PTBD as an effective procedure in most jaundiced neoplas-
tic patients because of the increased cure rate of cholangitis and the low procedure-
related mortality rate. This is also supported by a satisfactory overall median
survival period of 6 months after PTBD.
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